Clozapine rechallenge after clozapine-induced myocarditis: A case report to validate a previously published protocol [0.03%]
氯丙嗪致心肌炎后重新使用氯丙嗪的案例报告及对先前发表方案有效性的验证
Sara J Russell,Matthew Josdal,Annabelle Wanson et al.
Sara J Russell et al.
Introduction: Clozapine is an effective antipsychotic indicated for treatment-resistant schizophrenia (TRS). Its use is limited by its extensive adverse effect profile featuring rare but serious consequences like clozapin...
Intranasal naloxone to treat suspected synthetic cannabinoid overdose: A case report and literature review [0.03%]
鼻用纳洛酮治疗疑似合成大麻素过量：一例病例报告及文献综述
Jaden Dickinson,Tiffany Buckley
Jaden Dickinson
Synthetic cannabinoids (SCs), such as K2 or spice, are potent, intoxicating, laboratory-produced compounds designed to mimic Δ9-tetrahydrocannabinol (Δ9-THC). Some SCs are full agonists that bind to cannabinoid receptors in the endocannab...
Clinical strategies for low-dose overlap initiation of buprenorphine and potential barriers to use [0.03%]
低剂量重叠法开始丁丙诺啡治疗的临床策略及潜在障碍
Austin Smith,Kaitlyn Weslosky,Ashley Haynes et al.
Austin Smith et al.
Dual long-acting injectable antipsychotic use in treatment-resistant schizophrenia with extensive hospitalization history: A case report [0.03%]
治疗难治性精神病且有长期住院史的双重长效抗精神病药物使用：病例报告
Lily Zheng,Archana Jhawar
Lily Zheng
Treatment-resistant schizophrenia (TRS) is a challenging condition to manage and can result in the need for dual antipsychotic prescribing especially after oral clozapine failure. Poor medication adherence is prevalent among patients with T...
Loxapine for the treatment of psychosis in Lewy body dementia: A case report [0.03%]
关于洛沙平治疗Lewy体痴呆精神病的病例报告
Leslie Wu,Archana Jhawar
Leslie Wu
Lewy body dementia (LBD) is a progressive neurological disorder characterized by dementia, parkinsonism, and psychotic symptoms. Treating psychosis in LBD is particularly challenging, especially given the high risk of extrapyramidal effects...
Comparison of droperidol and haloperidol for acute agitation in the emergency department: A retrospective cohort study [0.03%]
一项回顾性队列研究：比较急诊科使用丁酰苯类抗精神病药（丁螺环酮和氟哌啶醇）治疗急性躁动的效果
Francesca DiGuglielmo,Melanie D&#x;Amico,Julianne Martine et al.
Francesca DiGuglielmo et al.
Introduction: To compare the effectiveness of droperidol and haloperidol for acute agitation in the emergency department. Methods: Data...
Henry Leach,Francesca DiGuglielmo
Henry Leach
Xanomeline/trospium is a newly approved agent for the management of schizophrenia. Unlike traditional antipsychotics, which are D2 receptor antagonists, xanomeline is an M1/M4 muscarinic acetylcholine receptor agonist coformulated with tros...
Memantine leading to physical aggression in the treatment of chronic catatonia secondary to schizophrenia: A case report [0.03%]
美金刚治疗慢性紧张症所致暴力行为的一例报告
Andrew Chantha Hean,Jessica Jones,Michael Arena et al.
Andrew Chantha Hean et al.
Introduction: Memantine is a noncompetitive N-methyl-D-aspartate receptor antagonist approved by the FDA for moderate to severe Alzheimer's dementia. Memantine is also recommended as an off-label treatment in current cata...
A potential case of refeeding syndrome in a patient with severe mental illness [0.03%]
一例严重精神疾病患者可能发生再喂养综合征的病例报告
Amber R Douglass,Eliana Spey,Kimberly A Ehrhard
Amber R Douglass
Refeeding syndrome (RFS) occurs when previously malnourished patients are reintroduced to nutritional support, triggering a metabolic response that often results in electrolyte abnormalities, vitamin deficiencies, and potential end organ di...